These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 30839510)

  • 1. 2-Methoxyestradiol Attenuates Angiotensin II-Induced Hypertension, Cardiovascular Remodeling, and Renal Injury.
    Salah E; Bastacky SI; Jackson EK; Tofovic SP
    J Cardiovasc Pharmacol; 2019 Mar; 73(3):165-177. PubMed ID: 30839510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of dimethylarginine dimethylaminohydrolase 1 protects from angiotensin II-induced cardiac hypertrophy and vascular remodeling.
    Kopaliani I; Jarzebska N; Billoff S; Kolouschek A; Martens-Lobenhoffer J; Bornstein SR; Bode-Böger SM; Ragavan VN; Weiss N; Mangoni AA; Deussen A; Rodionov RN
    Am J Physiol Heart Circ Physiol; 2021 Nov; 321(5):H825-H838. PubMed ID: 34533401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baicalein attenuates angiotensin II-induced cardiac remodeling via inhibition of AKT/mTOR, ERK1/2, NF-κB, and calcineurin signaling pathways in mice.
    Wang AW; Song L; Miao J; Wang HX; Tian C; Jiang X; Han QY; Yu L; Liu Y; Du J; Xia YL; Li HH
    Am J Hypertens; 2015 Apr; 28(4):518-26. PubMed ID: 25362112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological inhibition and genetic deficiency of plasminogen activator inhibitor-1 attenuates angiotensin II/salt-induced aortic remodeling.
    Weisberg AD; Albornoz F; Griffin JP; Crandall DL; Elokdah H; Fogo AB; Vaughan DE; Brown NJ
    Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):365-71. PubMed ID: 15576638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renovascular remodeling and renal injury after extended angiotensin II infusion.
    Casare FA; Thieme K; Costa-Pessoa JM; Rossoni LV; Couto GK; Fernandes FB; Casarini DE; Oliveira-Souza M
    Am J Physiol Renal Physiol; 2016 Jun; 310(11):F1295-307. PubMed ID: 26962104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Xin-Ji-Er-Kang formula on 2K1C-induced hypertension and cardiovascular remodeling in rats.
    Guo K; Lan CZ; Yu TT; Huang LL; Wang XH; Pan C; Gao S
    J Ethnopharmacol; 2014 Sep; 155(2):1227-35. PubMed ID: 25063306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the calpain/calpastatin system as a new strategy to prevent cardiovascular remodeling in angiotensin II-induced hypertension.
    Letavernier E; Perez J; Bellocq A; Mesnard L; de Castro Keller A; Haymann JP; Baud L
    Circ Res; 2008 Mar; 102(6):720-8. PubMed ID: 18258859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardioprotective effects of granulocyte colony-stimulating factor in angiotensin II-induced cardiac remodelling.
    Jia N; Dong P; Huang Q; Jin W; Zhang J; Dai Q; Liu S
    Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):262-6. PubMed ID: 18785976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dapagliflozin: a sodium-glucose cotransporter 2 inhibitor, attenuates angiotensin II-induced cardiac fibrotic remodeling by regulating TGFβ1/Smad signaling.
    Zhang Y; Lin X; Chu Y; Chen X; Du H; Zhang H; Xu C; Xie H; Ruan Q; Lin J; Liu J; Zeng J; Ma K; Chai D
    Cardiovasc Diabetol; 2021 Jun; 20(1):121. PubMed ID: 34116674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estradiol metabolites attenuate renal and cardiovascular injury induced by chronic nitric oxide synthase inhibition.
    Tofovic SP; Salah EM; Dubey RK; Melhem MF; Jackson EK
    J Cardiovasc Pharmacol; 2005 Jul; 46(1):25-35. PubMed ID: 15965351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of angiotensin II-induced cardiac remodeling by angiotensin-(1-7).
    Grobe JL; Mecca AP; Lingis M; Shenoy V; Bolton TA; Machado JM; Speth RC; Raizada MK; Katovich MJ
    Am J Physiol Heart Circ Physiol; 2007 Feb; 292(2):H736-42. PubMed ID: 17098828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the transcription factor erythroblastosis virus E26 oncogen homolog-1 (ETS-1) as mediator of the renal proinflammatory and profibrotic effects of angiotensin II.
    Feng W; Chumley P; Hua P; Rezonzew G; Jaimes D; Duckworth MW; Xing D; Jaimes EA
    Hypertension; 2012 Nov; 60(5):1226-33. PubMed ID: 22966006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-Methoxyestradiol Reduces Angiotensin II-Induced Hypertension and Renal Dysfunction in Ovariectomized Female and Intact Male Mice.
    Pingili AK; Davidge KN; Thirunavukkarasu S; Khan NS; Katsurada A; Majid DSA; Gonzalez FJ; Navar LG; Malik KU
    Hypertension; 2017 Jun; 69(6):1104-1112. PubMed ID: 28416584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-(1-7) improves cardiac remodeling and inhibits growth-promoting pathways in the heart of fructose-fed rats.
    Giani JF; Muñoz MC; Mayer MA; Veiras LC; Arranz C; Taira CA; Turyn D; Toblli JE; Dominici FP
    Am J Physiol Heart Circ Physiol; 2010 Mar; 298(3):H1003-13. PubMed ID: 20061544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neohesperidin inhibits cardiac remodeling induced by Ang II in vivo and in vitro.
    Zhang J; Fu X; Yang L; Wen H; Zhang L; Liu F; Lou Y; Yang Q; Ding Y
    Biomed Pharmacother; 2020 Sep; 129():110364. PubMed ID: 32531678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intermedin alleviates pathological cardiac remodeling by upregulating klotho.
    Zhang LS; Liu Y; Chen Y; Ren JL; Zhang YR; Yu YR; Jia MZ; Ning ZP; Du J; Tang CS; Qi YF
    Pharmacol Res; 2020 Sep; 159():104926. PubMed ID: 32502636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-Ethoxyestradiol is antimitogenic and attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling.
    Tofovic SP; Zhang X; Zhu H; Jackson EK; Rafikova O; Petrusevska G
    Vascul Pharmacol; 2008; 48(4-6):174-83. PubMed ID: 18373958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruption of the cytochrome P-450 1B1 gene exacerbates renal dysfunction and damage associated with angiotensin II-induced hypertension in female mice.
    Jennings BL; Moore JA; Pingili AK; Estes AM; Fang XR; Kanu A; Gonzalez FJ; Malik KU
    Am J Physiol Renal Physiol; 2015 May; 308(9):F981-92. PubMed ID: 25694484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardioprotection Conferred by Sitagliptin Is Associated with Reduced Cardiac Angiotensin II/Angiotensin-(1-7) Balance in Experimental Chronic Kidney Disease.
    Beraldo JI; Benetti A; Borges-Júnior FA; Arruda-Junior DF; Martins FL; Jensen L; Dariolli R; Shimizu MH; Seguro AC; Luchi WM; Girardi ACC
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31010001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic administration of angiotensin-(1-7) attenuates pressure-overload left ventricular hypertrophy and fibrosis in rats.
    Wang LJ; He JG; Ma H; Cai YM; Liao XX; Zeng WT; Liu J; Wang LC
    Di Yi Jun Yi Da Xue Xue Bao; 2005 May; 25(5):481-7. PubMed ID: 15897115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.